Finance

Lists
002422:SHE
Sichuan Kelun Pharmaceutical Co Ltd
CNÂ¥41.92
+0.24%
(+0.100) 1D
Sep 4, 3:04:06 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002422...
Open
CNÂ¥41.91
High
CNÂ¥42.44
Low
CNÂ¥41.58
Mkt. cap
66.42B
Avg. vol.
33.25M
Volume
13.00M
Dividend
1.42%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
May 11, 2026
P/E ratio
36.37
52-wk high
CNÂ¥52.78
52-wk low
CNÂ¥28.14
EPS
CNÂ¥1.15
Shares outstanding
1.59B
No. of employees
20K
Open
CNÂ¥41.91
High
CNÂ¥42.44
Low
CNÂ¥41.58
Mkt. cap
66.42B
Avg. vol.
33.25M
Volume
13.00M
Dividend
1.42%
Quarterly dividend
CNÂ¥0.15
Ex-dividend date
May 11, 2026
P/E ratio
36.37
52-wk high
CNÂ¥52.78
52-wk low
CNÂ¥28.14
EPS
CNÂ¥1.15
Shares outstanding
1.59B
No. of employees
20K
About Sichuan Kelun Pharmaceutical Co Ltd
CEO-
Employees20.1K
Founded1996
Headquarters-
SectorPharmaceutical industry
Websitekelun.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
4.19B
5.24B
4.26B
4.58B
Cost of goods sold
2.29B
2.85B
2.33B
2.36B
Cost of revenue
2.29B
2.85B
2.33B
2.36B
Research and development expenses
584.41M
572.64M
586.14M
626.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.03B
1.17B
992.40M
1.11B
Operating expense
1.51B
1.97B
1.66B
1.75B
Total operating expenses
3.80B
4.82B
3.99B
4.11B
Operating income
390.58M
416.66M
271.42M
473.04M
Other non operating income
-139.75M
146.54M
82.48M
-86.55M
EBT including unusual items
231.28M
754.91M
441.05M
1.11B
EBT excluding unusual items
292.43M
562.20M
407.20M
405.94M
Income tax expense
100.37M
122.46M
-31.65M
158.57M
Effective tax rate
43.40%
16.22%
-7.18%
14.26%
Other operating expenses
-103.78M
233.64M
66.32M
507.56K
Net income
200.04M
501.27M
453.70M
674.07M
Net profit margin
4.77%
9.57%
10.65%
14.72%
Earnings per share
-
-
-
-
Interest and investment income
72.25M
63.65M
76.41M
57.89M
Interest expense
-29.99M
-19.09M
-23.12M
-24.71M
Net interest expenses
42.26M
44.56M
53.29M
33.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
691.68M
739.75M
594.51M
806.81M
Gain or loss from assets sale
3.30M
-5.32M
-
-1.68M
AI content may include mistakes. Learn more
Google apps